新冠病毒感染后肺纤维化诊治研究进展  

Research Progress in the Diagnosis and Treatment of Pulmonary Fibrosis after Novel Coronavirus Infection

作　　者：栗萱 李湘 田应选[2] 

机构地区：[1]延安大学医学院,陕西 延安 [2]陕西省人民医院呼吸内二科,陕西 西安

出　　处：《临床医学进展》2024年第12期276-283,共8页Advances in Clinical Medicine

基　　金：1) 陕西省自然科学基础研究计划重点项目(2022JZ-59);2) 陕西省人民医院拔尖人才项目:(2021BJ-22);3) 陕西省科技厅社会发展研究项目:(2023-YBSF-064)。

摘　　要：新冠病毒(COVID-19)感染对人类健康造成了极大的危害。虽然大流行已经得到控制,但COVID-19感染带来的长新冠综合征依然影响着出院后患者的健康和生活质量,涉及呼吸、心血管、神经等多个系统。COVID-19感染后肺纤维化(PCPF)是呼吸系统方面的常见问题,具有很高的发生率。但是目前,临床对PCPF的诊断、治疗、疾病转归等方面的研究尚较少。本文就相关文献资料进行综述,期望对PCPF的临床诊治提供参考借鉴。COVID-19 infection has caused great harm to human health. Although the pandemic has been brought under control, the long COVID syndrome caused by COVID-19 infection still affects the health and quality of life of patients after discharge, involving multiple systems such as respiratory, cardiovascular, and neurological. Post-COVID-19 pulmonary fibrosis (PCPF) is a common respiratory problem with a high incidence. However, at present, there are few clinical studies on the diagnosis, treatment, and disease outcome of PCPF. This article reviews the relevant literature and expects to provide reference for the clinical diagnosis and treatment of PCPF.

关 键 词：COVID-19感染 肺间质纤维化 临床特征 诊断治疗 

分 类 号：R73[医药卫生—肿瘤]